Extraskeletal effects and manifestations of Vitamin D deficiency

R Kasi Visweswaran, H Lekha, R Kasi Visweswaran, H Lekha

Abstract

The actions of vitamin D are not confined to bone. Vitamin D receptors are present in nearly all the nuclei and its actions are manifold. Populations deficient in vitamin D are at higher risk of developing autoimmune diseases, diabetes, cancer, infections, allergies and other chronic illnesses.

Keywords: Allergies; Vitamin D; asthma; autoimmune disease; cancer; cardiovascular; diabetes; extraskeletal; falls; infections.

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Holick MF. Evolution and function of Vitamin D. Recent Results Cancer Res. 2003;164:3–28.
    1. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardiovascular disease. Am J Clin Nutr. 2004;80(6 Suppl):1678S–88S.
    1. Holick MF. Resurrection of Vitamin D deficiency and rickets. J Clin Invest. 2006;116:2062–72.
    1. Spiesman EG. Massive doses of vitamin A and D in the prevention of common cold. Arch Otolaryn. 1941;34:789–91.
    1. Cannel JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134:1129–40.
    1. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, et al. A global study of vitamin D status and parathyroid function in post menopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifine evaluation clinical trial. J clin Endocrinol Metab. 2001;86:1212–21.
    1. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6 Suppl):S1678–88.
    1. Hoffman FL. Appendix E. Newark (NJ): Prudential Press; 1915. The mortality of cancer throughout the world.
    1. Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res. 1941;1:191–5.
    1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.
    1. Christakos S, Dhawan P, Liu Y, Peng X, Porta A. New insights into the mechanisms of vitamin D action. J Cell Biochem. 2003;88:669–705.
    1. Dusso AS, Brown AJ, Slatopolsky Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8–28.
    1. Holick MF. Vitamin D: A millennium perspective. J cell Biochem. 2003;88:296–307.
    1. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, et al. 1 alpha,25-Dihydroxycholecalciferol and human myeloid leukemia cell line(HL-60) Biochem J. 1982;204:713–9.
    1. Colston K, Colston MJ, Felsman D. 1,25 dihydroxyvitamin D 3 and malignant melanoma:the presence of receptors and inhibition of cell growth in culture. Endocrinology. 1981;108:1083–6.
    1. Cross HS, Bareis, Hofer H, Bischof MG, Bajna E, Kriwanek S, et al. 25 hydroxyvitamin D 3 1hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early carcinogenesis. Steroids. 2001;66:287–92.
    1. Feldman D, Zhao XY, Krishnan AV. Vitamin D and prostate cancer. Endocrinology. 2000;141:5–9.
    1. Gknos PJ, London R, Hendler ED. Hypercalcemia and elevated 1,25 dihydroxy vitamin D levels in a patient with end stage renal disease and active tuberculosis. N Engl J Med. 1984;311:1683–5.
    1. Adams JS, Singer FR, Gacad MA, Sharma OP, Hayes MJ, Vouros P, et al. Isolation and structural identification of 1,25 dihydroxy vitamin D 3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab. 1985;60:960–6.
    1. Tangpricha V, Flanagan JN, Whitlateh LW, Tseng CC, Chen TC, Holt PR, et al. 25 hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001;357:1673–4.
    1. Mawer EB, Hayes ME, Heys SE, Davies M, White A, Stewart MF, et al. Constitutive synthesis of 1,25 dihydroxy vitamin D 3 by a human small cell lung cell line. J Clin Endocrinol Metab. 1994;79:554–60.
    1. Garland CF, Garland FC, Gorham ED. Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr. 1991;54:93S–201S.
    1. DeLuca H. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6,suppl):1689S–96S.
    1. Holick MF. Non calcaemic actions of 1,25 dihydroxy vitaminD 3 and clinical applications. Bone. 1995;17:107S–11S.
    1. Bikle DD, Nemanic MK, Gee E, Elias P. 1,25 dihydroxy D 3 production by human keratinocytes. Kinetics and regulation. J Clin Invest. 1986;78:557–66.
    1. Holick MF. Vitamin D: The underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes. 2002;9:87–98.
    1. Hanchette CL, Scwartz GG. Geographic patterns of prostate cancer mortality. Cancer. 1992;70:2861–9.
    1. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25 hydroxy vitamin D and colon cancer: Eight year prospective study. Lancer. 1989;18:1176–8.
    1. Khazai N, Judd SE, Tangpricha V. Calcium and vitamin D: Skeletal and extraskeletal health. Curr Rheumatol Rep. 2008;10:110–7.
    1. Nagpal S, Na S, Rathachalam R. Non calcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–87.
    1. Bikle DD. Noncalcemic actions of vitamin D. J Clin Endocrinol Metab. 2009;94:26–34.
    1. Holick MF. Vitamin D: Extraskeletal health. Endocrinol Metab Clin N Am. 2010;39:381–400.
    1. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004;158:531.
    1. Cole CR, Grant FK, Tangpricha V, Swaby-Ellis ED, Smith JL, Jacques A, et al. 25-hydroxyvitamin D status of healthy, low income, minority children in Atlanta, Georgia. Pediatrics. 2010;125:633–9.
    1. Razzaghy Azar M, Shakiba M. Assessment of vitamin D status in healthy children and adolescents living in Tehran and its relation to iPTH, gender, weight and height. Ann Hum Biol. 2010;37:692–701.
    1. Mansbach JM, Ginde AA, Camargo CA., Jr Serum 25OHD levels among US children aged 1 to 11 years: Do children need more vitamin D? Pediatrics. 2009;124:1404–10.
    1. Rovner AJ, O’Brien KD. Hypovitaminosis D among healthy children in the United States: A review of the current evidence. Arch Pediatr Adolesc Med. 2008;162:513–9.
    1. Hodgkin P, Kay, Liumb GA, Stranbury SW. Vitamin D deficiency in Asians at home and in Britain. Lancet. 1973;2:167–72.
    1. Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism. Clin Endocrinol. 1995;43:351–8.
    1. Goswami R, Gupta N, Goswami D, Marwala RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxyvitamin D concentration in healthy subjects in Delhi. Am J Clin Nutr. 2000;72:472–5.
    1. Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D, Srinivasarao PV, Sarma KV, et al. High prevalence of low dietary calcium, high phytate consumption and vitamin D deficiency in healthy south Indians. Am J Clin Nutr. 2007;85:1062–7.
    1. Harinarayan CV, Joshi SR. Vitamin D status in India--Its implications and remedial measures. J Assoc Physicians India. 2009;57:40–8.
    1. Holick MF. Vitamin D: Importance in the prevention of cancers, type I diabetes, heart disease and osteoporosis. Am J Clin Nutr. 2004;79:362–71.
    1. Lips P, Wiersinga A, van Ginkel FC, Jongen MJ, Netelenbos JC, Hackeng WH, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab. 1988;67:644–50.
    1. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr. 2004;80(6 Suppl):1706S–9S.
    1. Gloth FM, Gundberg CM, Hollis BW, Haddad JG, Jr, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA. 1995;274:1683–6.
    1. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25 hydroxy vitamin D. J Am Coll Nutr. 2003;22:142–6.
    1. om D Thacher, Bart L Clarke. Vitamin D insufficiency. Mayo Clin Proc. 2011;86:50–60.
    1. Fiscella K, Franker P. Vitamin D, race and cardiovascular mortality with findings from a national US sample. Ann Fam Med. 2010;8:11–8.
    1. Giovannucci E, Lui Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med. 2008;168:1174–80.
    1. Fleck A. Latitude and ischemic heart disease. Lancet. 1989;1:613.
    1. Grimes DS, Hindle E, Dyer T. Sunlight, cholesterol and coronary heart disease. QJM. 1996;89:579–89.
    1. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–11.
    1. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93:3927–35.
    1. Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, Boehm BO, et al. Low Vitamin D levels predict stroke in patients referred to coronary angiography. Stroke. 2008;39:2611–3.
    1. Wolf M, Shah A, Guterraz O, Ankers E, Monroy M, Tamez H, et al. Vitamin D levels and early motality among incident hemodialysis patients. Kidney Int. 2007;72:1004–13.
    1. Rajasree S, Rajpal K, Kartha CC, Sarma PS, Kutty VR, Iyer CS, et al. Serum 25-hydroxyvitamin D 3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol. 2001;17:567–71.
    1. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063–9.
    1. Forman JP, Curhan GC, Taylor EM. Plasma 25-hydroxyvitamin D levels and risk of hypertension among young women. Hypertension. 2008;52:828–32.
    1. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short term vitamin D (3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2007;86:1633–7.
    1. Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet. 1998;352:709–10.
    1. Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D 3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995;49:640–6.
    1. Lacroix AZ, Kotchen J, Anderson G, Brzyski R, Cauley JA, Cummings SR, et al. Calcium plus vitamin D supplementation and mortality in post menopausal women: The women's health initiative calcium-vitamin D randomized control trial. J Gerontol A Biol Sci Med Sci. 2009;64:559–67.
    1. Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009;338:40–4.
    1. Triwedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D 3 supplementation on fractures and mortality in men and women living in the community: Randomized double blind control trial. BMJ. 2003;326:469.
    1. Motiwala SR, Wang TJ. Vitamin d and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011;20:345–53.
    1. Elamin MB, Abu Ehnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, et al. Vitamin d and cardiovascular outcomes: A systematic review and meta analysis. J Clin Endocrinol Metab. 2011;96:1931–42.
    1. Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009;35:11–7.
    1. Mathieu C, Waer M, Carteels K, Laureys J, Bouillon R. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology. 1995;136:866–72.
    1. Gregori S, Giarratana N, Smiroldo S, Uskokovie M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002;51:1367–74.
    1. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: A systematic review and meta-analysis. Arch Dis Child. 2008;93:512–7.
    1. Vitamin D supplement in early childhood and risk for Type I (insulin- dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia. 1999;42:51–4.
    1. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet. 2001;358:1500–3.
    1. Fronczak CM, Baron AE, Chase HP, Ross C, Brady HL, et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care. 2003;26:3237–92.
    1. Ishii H, Suzuki H, Baba T, Nakamura K, Watanabe T. Seasonal variation of glycemic control in type 2 diabetic patients. Diabetes Care. 2001;24:1503.
    1. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30:980–6.
    1. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes care. 2008;31:701–707.
    1. Scragg R, Sowers M, Bell C. Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2813–8.
    1. Pietschmann P, Schernthaner G, woloszczuk W. Serum osteocalcin levels in diabetes mellitus: Analysis of the type of diabetes and microvascular complications. Diabetologia. 1988;31:892–5.
    1. Isaia G, Giorgino R, Adani S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care. 2001;24:1496.
    1. Mattila C, Knelct P, Mannisto S, Rissanen H, Laaksonen MA, Montonen J. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007;30:2569–70.
    1. Knelct P, Laaksonen M, Mattila C, Harkanen T, Marniemi J, Heliövaara M, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19:666–71.
    1. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995;38:1239–45.
    1. Fliser D, Stefanski A, Frank E, Fode P, Gudarzi A, Ritz E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest. 1997;27:629–33.
    1. Pittas AG, Lau J, Hu B, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes: A systematic review and metaanalysis. J Clin Endocrinol Metab. 2007;92:2017–29.
    1. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, et al. Vitamin D Receptor Gene Polymorphisms and Breast Cancer Risk. Clin Cancer Res. 2004;10:5472–81.
    1. Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R. Vitamin D and reduced risk of breast cancer: A population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2007;16:422–99.
    1. Grant WB. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer. 2002;94:272–81.
    1. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qui H. Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies. J Clin Oncol. 2011;29:3775–82.
    1. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: Potential for anticancer therapeutics. Nat Rev Cancer. 2007;7:684–700.
    1. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr. 2007;85:1586–91.
    1. Koeffler HP, Hirjik J, Iti L. 1,25-Dihydroxyvitamin D3: In vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep. 1985;69:1399–407.
    1. Pálmer HG, Larriba MJ, García JM, Ordóñez-Morán P, Peña C, Peiró S, et al. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med. 2004;9:917–9.
    1. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009;5:e1000369. Epub 2009 Feb 6.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner